Use of the PFA-100™ closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis
- 1 March 2008
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 6 (3), 444-450
- https://doi.org/10.1111/j.1538-7836.2008.02897.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Using the Platelet Function Analyzer-100 for monitoring aspirin therapyThrombosis Research, 2007
- Determination of Aspirin Responsiveness by Use of Whole Blood Platelet AggregometryClinical Chemistry, 2007
- Prevalence of persistent platelet reactivity despite use of aspirin: A systematic reviewAmerican Heart Journal, 2007
- Usefulness of Aspirin Resistance After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Predicting One-Year Major Adverse Coronary EventsThe American Journal of Cardiology, 2006
- Biological effects of aspirin and clopidogrel in a randomized cross‐over study in 96 healthy volunteersJournal of Thrombosis and Haemostasis, 2006
- The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosisAmerican Heart Journal, 2005
- Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarctionThe American Journal of Cardiology, 2005
- Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?American Heart Journal, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- ReviewBritish Journal of Haematology, 2000